A shadow market for unlicensed weight-loss drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.
Experimental Treatment Acquiring Popularity Via Social Media
The experimental drug, which is still in research studies, is being advertised by online personalities for its supposed weight-reducing effects. Viewers are encouraged to contact these profiles privately for supplier links, while also obtaining promotional offers.
Active Commerce on Messaging Platforms
Separately, a robust market exists on Telegram, where groups with thousands of participants share “before and after” photos, injection guides and claims of rapid UK delivery. Sellers promote the substance there before redirecting buyers to WhatsApp for transactions.
Understanding The Experimental Drug
Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Healthcare Professionals Voice Concerns
Nevertheless, physicians and chemists have warned that the sale of what remains an unlicensed medication in the United Kingdom is a cause for concern and could lead to individuals administering substances of uncertain source.
Several professionals said the demand for retatrutide could be connected to the increasing price of approved slimming products such as Mounjaro.
Legal Status and Enforcement
Selling the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Several content creators attempt to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still violate medicines, advertising, and customer laws, risking penalties, prosecution or imprisonment.
Service Response and Content Removal
Based on TikTok, the platform has taken down problematic content and banned associated hashtags and query recommendations. The company said it was committed to keeping the platform secure and investing in enhancing enforcement strategies.
Digital Marketplace Operations
Research also found communities with up to nine thousand members marketing retatrutide using Telegram's integrated discovery tool, which functions like a public directory. Typing “retatrutide” instantly brings up groups with thousands of users, filled with photos of weight loss, positive testimonials and detailed guides for mixing or injecting at residence.
Within minutes of entering one group, a seller shared WhatsApp details, where the majority of transactions take place. The vendor provided an instruction manual and guaranteed shipping within two days. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a image of a alleged testing documentation. None inquired about weight, health issues or past usage.
Item Information and Costs
Inside these communities, posts show dark colored packages with postal service stickers, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at home with sterile water, or pre-filled pens typically sold at 160 pounds for 20 milligrams. When asked how long a injector should be used, sellers give contradictory answers varying between a several days to “depends on your body”.
Service Oversight and Safety Measures
A spokesperson for Telegram stated it regularly moderated harmful content on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are injecting substances they cannot confirm. Although the research behind this drug is valid, these online versions may not contain what they advertise,” stated a pharmacy expert, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the surge in interest to current price rises for authorized slimming drugs such as Mounjaro. “With costs increasing, individuals are using social media. But fake treatments are highly risky. You cannot know what’s inside or whether the environment they were made in was clean,” she explained.
Her staff has already seen individuals harmed by personal administration from unverified sources. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Statement
A spokesperson from Eli Lilly stated retatrutide was in phase 3 research studies and had not been evaluated or authorized by any government authority globally. “Therefore at this point no one can sell [it] for human use,” they said, noting that any product “misleadingly claiming itself as a company experimental product not yet authorized … may subject users to potentially serious health risks”.
